Breast cancer treatment and treatment prediction

Details for Australian Patent Application No. 2008339080 (hide)

Owner ATLAS ANTIBODIES AB

Inventors Uhlen, Mathias; Jirstrom, Karin; Ponten, Fredrik

Agent Griffith Hack

Pub. Number AU-A-2008339080

PCT Pub. Number WO2009/078783

Priority 61/014,241 17.12.07 US; 7150072.2 17.12.07 EP

Filing date 16 December 2008

Wipo publication date 25 June 2009

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/078783 Priority application(s): WO2009/078783

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339082-Methods and devices for communicating over a radio channel

2008339048-Thrust generator